Views & Analysis Coronavirus pharma conference monitor – event impact of COVI... The COVID-19 coronavirus epidemic that originated in Wuhan, the capital of China’s Hubei province, has wide-ranging implications for the pharmaceutical industry and healthcare sector alike.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
